Article

Sensitivity of BA.2.86 to prevailing neutralising antibody responses

2023-09-04

Abstract excerpt

A new SARS-CoV-2 variant, designated BA.2.86, has recently emerged with over 30 spike mutations relative to its parental BA.2, raising questions about its degree of resistance to neutralising antibodies. Using a spike-pseudotyped virus model we characterise neutralisation of BA.2.86 by clinically relevant monoclonal antibodies and by two cohorts of serum sampled from Stockholm, including both a recent cohort, and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 52b6611a-0232-52a0-ad56-aa4f6f7991af
DOI: 10.1101/2023.09.02.556033

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Sensitivity of BA.2.86 to prevailing neutralising antibody responsesDOI 10.1101/2023.09.02.556033Read

Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike.Semantic proximity Read

Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spikeSemantic proximity Read

Evasion of neutralizing antibodies by Omicron sublineage BA.2.75Semantic proximity Read

Reverse mutational scanning of SARS-CoV-2 spike BA.2.86 identifies epitopes contributing to immune escape from polyclonal seraSemantic proximity Read

Host cell entry and neutralisation sensitivity of SARS-CoV-2 BA.3.2Semantic proximity Read

SARS-CoV-2 spike E484K mutation reduces antibody neutralisationSemantic proximity Read

Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies.Semantic proximity Read

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86Semantic proximity Read

Evasion of Neutralizing Antibody Response by the SARS-CoC-2 BA.2.75 VariantSemantic proximity Read

SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthroughSemantic proximity Read

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernSemantic proximity Read

SARS-CoV-2 Omicron BA.5: Evolving Tropism and Evasion of Potent Humoral Responses and Resistance to Clinical Immunotherapeutics Relative to Viral Variants of ConcernSemantic proximity Read